NewLink Genetics to Present at Upcoming Investor Conferences

Monday, June 7, 2010 General News J E 4
AMES, Iowa, June 7 NewLink Genetics Corporation today announced that Charles Link, M.D., chairman and chief executive officer, will present at the following investor conferences:

Dr. Link will provide an overview of NewLink and its clinical development programs including HyperAcute®-Pancreas Immunotherapy which recently entered Phase 3 testing and presented Phase 2 data at ASCO.

About NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company applying innovative technologies to create new therapeutic agents for patients with cancer and infectious diseases. Its products are designed to enhance the patient's immune system, enabling the body's immune cells to target pathogens and diseased tissues. For more information please visit us at

-- The 9th Annual Needham Healthcare Conference, Thursday, June 10, at 11:40 a.m. Eastern Time in New York City, NY. The presentation will be webcast live and available for replay at -- The Wells Fargo Securities 2010 Healthcare Conference, Wednesday, June 23, at 1:00 p.m. Eastern Time in Boston, MA.

SOURCE NewLink Genetics Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Institute for Functional Medicine Holds First Glob...
Drugs in R&D Gets Reinvented as an Open Access Jou...